NasdaqGM - Delayed Quote USD

iShares Biotechnology ETF (IBB)

136.69 -0.60 (-0.44%)
At close: May 17 at 4:00 PM EDT
136.69 0.00 (0.00%)
After hours: May 17 at 5:13 PM EDT

Top 10 Holdings (51.30% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 8.73%
VRTX
Vertex Pharmaceuticals Incorporated 8.15%
REGN
Regeneron Pharmaceuticals, Inc. 8.05%
GILD
Gilead Sciences, Inc. 7.89%
IQV
IQVIA Holdings Inc. 4.42%
MRNA
Moderna, Inc. 3.93%
BIIB
Biogen Inc. 3.29%
MTD
Mettler-Toledo International Inc. 2.76%
ILMN
Illumina, Inc. 2.07%
ARGX
argenx SE 2.00%

Sector Weightings

SectorIBB
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.92%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.04
Price/Book 0.25
Price/Sales 0.18
Price/Cashflow 0.06
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

ETF Overview

Category Health
Fund Family iShares
Net Assets 6.99B
YTD Daily Total Return 0.71%
Yield 0.32%
Legal Type Exchange Traded Fund

Related Tickers